antiretroviral treatment for childrenCipla

24 Jun 2022

SAHPRA approves breakthrough granule treatment for children with HIV

By Staff Writer

SAHPRA has registered a new ‘sweet-tasting’ combination antiretroviral treatment in granule format for infants and young children with HIV. The ‘4-in-1’ formulation with the trade name Quadrimune has been developed by the non-profit entity, Drugs for Neglected Diseases initiative (DNDi) and Cipla. The treatment is supplied in a granule format, which can be sprinkled on soft...

13 Mar 2020

Cipla develops child-friendly treatment for children living with HIV

By Staff Writer

Cipla has prioritised the development of optimal child-friendly antiretroviral formulations for children living with HIV (CLHIV), specifically infants and young children at highest risk of dying without the access to treatment. Almost all parents can attest to the struggle experienced at mealtimes – think aeroplane noises and bribery – to get an infant or toddler...